Florence Zhu
Keine laufenden Positionen mehr
Profil
Florence Zhu worked as a Vice President-Finance & Controller at Olema Pharmaceuticals, Inc., Controller at Forty Seven, Inc., Controller at Prime Therapeutics LLC, Assistant Controller at Maxygen, Inc., and Director-External Reporting at Codexis, Inc. Ms. Zhu obtained an undergraduate degree from State University of New York College at New Paltz.
Ehemalige bekannte Positionen von Florence Zhu
| Unternehmen | Position | Ende |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.01.2021 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
| CODEXIS, INC. | Corporate Officer/Principal | - |
Prime Therapeutics LLC
 Prime Therapeutics LLC Managed Health CareHealth Services Prime Therapeutics LLC provides pharmacy benefits and services to insurance providers. The company manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. It processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. The company was founded on August 28, 1998 and is headquartered in Eagan, MN. | Comptroller/Controller/Auditor | - |
| FORTY SEVEN, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Florence Zhu
| State University of New York College at New Paltz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CODEXIS, INC. | Process Industries |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Prime Therapeutics LLC
Prime Therapeutics LLC Managed Health CareHealth Services Prime Therapeutics LLC provides pharmacy benefits and services to insurance providers. The company manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. It processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. The company was founded on August 28, 1998 and is headquartered in Eagan, MN. | Health Services |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
